Status:

COMPLETED

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

Lead Sponsor:

BRIM Biotechnology Inc.

Collaborating Sponsors:

ORA, Inc.

Conditions:

Dry Eye Syndrome

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

Detailed Description

This is a multi-center, double-masked, randomized, placebo-controlled, phase 2/3 study with approximately 200 subjects. (around 100 subjects per treatment arm).

Eligibility Criteria

Inclusion

  • Be at least 18 years of age;
  • Provide written informed consent;
  • Have a reported history of dry eye for at least 6 months prior to enrollment;
  • Have a history of use of eye drops

Exclusion

  • Have any clinically significant slit lamp findings at Visit 1 that may include active blepharitis, meibomian gland dysfunction (MGD), lid margin inflammation or active ocular allergies that require therapeutic treatment, and/or in the opinion of the investigator may interfere with study parameters;
  • Be diagnosed with an ongoing ocular infection (bacterial, viral, or fungal), or active ocular inflammation at Visit 1;
  • Have worn contact lenses within 7 days of Visit 1 or anticipate using contact lenses during the study;
  • Have used any eye drops within 2 hours of Visit 1;
  • Have previously had laser-assisted in situ keratomileusis (LASIK) surgery within the last 12 months;
  • Be a woman of childbearing potential who is not using an acceptable means of birth control; acceptable methods of contraception

Key Trial Info

Start Date :

January 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 23 2020

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT04343287

Start Date

January 15 2020

End Date

June 23 2020

Last Update

October 21 2021

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Eye Research Foundation

Newport Beach, California, United States, 92663

2

Midwest Cornea Associates, LLC

Indianapolis, Indiana, United States, 46290

3

Andover Eye Associates

Andover, Massachusetts, United States, 01810

4

Total Eye Care

Memphis, Tennessee, United States, 38119